You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,854,259


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,854,259
Title: Quinoline type mevalonolactones
Abstract:Described herein are mevalonolactone derivatives having a quinoline ring of formula (I) ##STR1## wherein the R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Y and Z variables are described therein.
Inventor(s): Fujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP), Sakashita; Mitsuaki (Saitama-ken, JP), Kitahara; Masaki (Saitama-ken, JP)
Assignee: Nissan Chemical Industries Ltd. (Tokyo, JP)
Application Number:07/978,884
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

United States Patent 5,854,259: A Detailed Analysis

Introduction

United States Patent 5,854,259, titled "Quinoline type mevalonolactones," is a patent that covers a specific class of chemical compounds and their applications. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Publication Number and Authority

The patent, US5854259A, was issued by the United States Patent and Trademark Office (USPTO) and is categorized under the authority of the United States[4].

Prior Art and Legal Status

The patent has expired, as indicated by its legal status. This means that the exclusive rights granted by the patent are no longer in effect, and the invention is now in the public domain[4].

Scope of the Patent

Technology Field

The patent pertains to the field of organic chemistry, specifically focusing on mevalonolactone derivatives that incorporate a quinoline ring. These compounds are described along with their corresponding dihydroxy carboxylic acids, salts, and esters[4].

Key Compounds and Structures

The patent details various structural variations of the mevalonolactone derivatives, including different substituents and functional groups. For example, it specifies the types of alkyl, cycloalkyl, and alkenyl groups that can be attached to the quinoline ring, as well as the preferred combinations of these groups[4].

Claims of the Patent

Independent and Dependent Claims

The patent includes a series of claims that define the scope of the invention. These claims are both independent and dependent, with the independent claims outlining the broadest aspects of the invention and the dependent claims providing more specific details.

  • Independent Claims: These claims define the core aspects of the mevalonolactone derivatives, including the quinoline ring and the various substituents.
  • Dependent Claims: These claims specify additional features or limitations of the compounds, such as specific combinations of substituents or preferred examples of the compounds[4].

Patent Landscape Analysis

Defining Scope and Keywords

To analyze the patent landscape around US5854259A, one must first define the scope of the analysis and identify relevant keywords. This involves determining the technology field (in this case, mevalonolactone derivatives and quinoline compounds) and the specific terms that best represent it[3].

Search and Organize Patents

Using patent databases such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, or the World Intellectual Property Organization's PATENTSCOPE, one can search for relevant patents based on the chosen keywords. Patents can be organized by factors like filing date, assignee, and technology subcategories[1][3].

Identify Trends and Key Players

The analysis should recognize patterns in patent filings and pinpoint significant contributors in the field of mevalonolactone derivatives. This involves identifying companies or inventors that have filed multiple patents in this area and understanding their roles in the technological advancements[3].

Analyze Citations and Evolution

Studying how patents reference each other helps in understanding their impact and development. The Common Citation Document (CCD) application can be particularly useful here, as it consolidates prior art cited by all participating offices for the family members of a patent application[1].

Insights from Patent Landscape Analysis

Technological Trends

A patent landscape analysis reveals ongoing innovations and trends within the specific technological domain. For mevalonolactone derivatives, this could include advancements in synthesis methods, new applications, or improvements in the properties of these compounds[3].

Key Players

Identifying key players helps in understanding the competitive landscape. Companies or research institutions that have a strong patent portfolio in this area are likely to be significant contributors to the field.

Legal Vulnerabilities

The analysis also highlights potential legal vulnerabilities. For instance, understanding the expiration dates of related patents and the current state of the art can help in navigating potential infringement issues[3].

Example of Related Patents

Other patents related to mevalonolactone derivatives or quinoline compounds can provide additional context. For example, patents that describe similar chemical structures or applications can be identified through comprehensive searches using the resources mentioned above[1].

Practical Applications and Decisions

Strategic Guidance

The insights gained from the patent landscape analysis can be translated into practical guidance for strategic decisions. This includes evaluating the competitive landscape, identifying potential collaborations or licensing opportunities, and assessing the strength of one's own patent portfolio[3].

Key Takeaways

  • Expired Patent: US5854259A is no longer in force, making its inventions public domain.
  • Scope and Claims: The patent covers specific mevalonolactone derivatives with a quinoline ring and various substituents.
  • Patent Landscape: Analyzing related patents helps in understanding technological trends, key players, and potential legal vulnerabilities.
  • Strategic Decisions: Insights from the analysis can guide strategic choices in research, development, and intellectual property management.

FAQs

Q: What is the current legal status of US5854259A? A: The patent has expired, meaning its exclusive rights are no longer in effect.

Q: What type of compounds does US5854259A cover? A: The patent covers mevalonolactone derivatives that incorporate a quinoline ring.

Q: How can one conduct a patent landscape analysis for this patent? A: By defining the scope, searching and organizing relevant patents, identifying trends and key players, and analyzing citations and evolution.

Q: What are the benefits of conducting a patent landscape analysis? A: It provides insights into technological trends, key players, and potential legal vulnerabilities, helping in making informed strategic decisions.

Q: Where can one find additional resources for patent searching and analysis? A: Resources include the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE[1][3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US Courts - Report on Filing Patent/Trademark: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark
  3. Goldstein Patent Law - How to Do Patent Landscape Analysis: https://www.goldsteinpatentlaw.com/how-to-patent-landscape-analysis/
  4. Google Patents - US5854259A: https://patents.google.com/patent/US5854259A/en
  5. Unified Patents - US-20060251720-A1: https://portal.unifiedpatents.com/patents/patent/US-20060251720-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,854,259

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,854,259

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-207224Aug 20, 1987
Japan63-15585Jan 26, 1988
Japan63-193606Aug 03, 1988

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.